296 Results
| Title | Release Date | Expiration Date |
|---|---|---|
Notice Notice of Early Expiration and Reissue of PAR-24-062, "Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)" NOT-DA-25-036 | Release Date | Expiration Date |
Notice Notice of Early Expiration and Reissue of PAR-24-060, "Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)" NOT-DA-25-035 | Release Date | Expiration Date |
Notice Notice of Change: NIDA Participation in RFA-EY-25-001: BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) NOT-DA-24-064 | Release Date | Expiration Date |
Notice Notice of Change to Eligibility Information for PAR-24-297, "Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)" NOT-DA-24-060 | Release Date | Expiration Date |
Notice Notice of Early Expiration and Reissue of RFA-DA-25-056, "Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trials Not Allowed)" NOT-DA-24-061 | Release Date | Expiration Date |
Notice Notice of Intent to Publish a Funding Opportunity Announcement for NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01) NOT-DA-24-052 | Release Date | Expiration Date |
Notice Notice of Intent to Publish a Funding Opportunity Announcement for NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34) NOT-DA-24-051 | Release Date | Expiration Date |
Notice Notice of Intent to Publish a Funding Opportunity for NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional) NOT-DA-24-049 | Release Date | Expiration Date |
Notice Notice of Intent to Publish a Funding Opportunity Announcement for Annual Conference in Therapeutics Development for Substance Use Disorders (U13 Clinical Trial Not Allowed) NOT-DA-25-033 | Release Date | Expiration Date |
Release Date | Expiration Date | |
Notice Notice of NIDA Participation in PA-25-080 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)" NOT-DA-24-050 | Release Date | Expiration Date |
Notice Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed) NOT-DA-24-047 | Release Date | Expiration Date |
Notice Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed) NOT-DA-24-046 | Release Date | Expiration Date |
Notice Notice of Question and Answer "Office Hours" with NIH Staff for the Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) Funding Opportunities RFA-DA-25-037, RFA-DA-25-038 NOT-DA-24-042 | Release Date | Expiration Date |
Notice Notice of Information: Updates to the Data Repository for the Adolescent Brain Cognitive Development (ABCD) Study and the HEALthy Brain and Child Development (HBCD) Study NOT-DA-24-038 | Release Date | Expiration Date |
Notice Notice of Clarification for PAR-23-269, PAR-23-125, "NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional) and Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial Optional)" NOT-DA-24-034 | Release Date | Expiration Date |
Notice Notice of NIDA's Participation in PA-24-246 "PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)" NOT-DA-24-036 | Release Date | Expiration Date |
Notice Notice of NIDA'S Participation in PA-24-248 "PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)" NOT-DA-24-037 | Release Date | Expiration Date |
Notice Notice of Question and Answer "Office Hours" with NIH Staff for NIDA Racial Equity Initiative Funding Opportunities RFA-DA-23-013, RFA-DA-23-026, RFA-DA-23-028, RFA-DA-23-029, RFA-DA-23-031, RFA-DA-23-032, RFA-DA-23-061, RFA-DA-23-062 NOT-DA-24-035 (R01,DP1,R34,R61/R33) | Release Date | Expiration Date |
Notice Notice to Alert the Public of NIDA's Career Development Award Salary Limits NOT-DA-24-032 (K25,K01,K99/R00) | Release Date | Expiration Date |
Notice Notice of Extension of the Expiration Date for PAR-21-282, "Blueprint Medtech: Small Business Translator (U44 Clinical Trial Optional)" NOT-DA-24-027 | Release Date | Expiration Date |
Notice Notice of Participation of NIDA in RFA-MH-25-186, "Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional)" NOT-DA-24-033 (R21) | Release Date | Expiration Date |
Notice Notice to Update PAR-23-194, "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)" NOT-DA-24-030 | Release Date | Expiration Date |
Notice Notice to Extend PAR-22-027, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)" NOT-DA-24-025 (R21) | Release Date | Expiration Date |
Release Date | Expiration Date |